Puerol BCAS# 112343-17-6 |
2D Structure
Quality Control & MSDS
3D structure
Package In Stock
Number of papers citing our products
Cas No. | 112343-17-6 | SDF | Download SDF |
PubChem ID | 56776306 | Appearance | Powder |
Formula | C18H16O5 | M.Wt | 312.3 |
Type of Compound | Flavonoids | Storage | Desiccate at -20°C |
Solubility | Soluble in Chloroform,Dichloromethane,Ethyl Acetate,DMSO,Acetone,etc. | ||
Chemical Name | 3-(2-hydroxy-4-methoxyphenyl)-2-[(4-hydroxyphenyl)methyl]-2H-furan-5-one | ||
SMILES | COC1=CC(=C(C=C1)C2=CC(=O)OC2CC3=CC=C(C=C3)O)O | ||
Standard InChIKey | KGPYRSBJENOECL-UHFFFAOYSA-N | ||
Standard InChI | InChI=1S/C18H16O5/c1-22-13-6-7-14(16(20)9-13)15-10-18(21)23-17(15)8-11-2-4-12(19)5-3-11/h2-7,9-10,17,19-20H,8H2,1H3 | ||
General tips | For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20℃ for several months. We recommend that you prepare and use the solution on the same day. However, if the test schedule requires, the stock solutions can be prepared in advance, and the stock solution must be sealed and stored below -20℃. In general, the stock solution can be kept for several months. Before use, we recommend that you leave the vial at room temperature for at least an hour before opening it. |
||
About Packaging | 1. The packaging of the product may be reversed during transportation, cause the high purity compounds to adhere to the neck or cap of the vial.Take the vail out of its packaging and shake gently until the compounds fall to the bottom of the vial. 2. For liquid products, please centrifuge at 500xg to gather the liquid to the bottom of the vial. 3. Try to avoid loss or contamination during the experiment. |
||
Shipping Condition | Packaging according to customer requirements(5mg, 10mg, 20mg and more). Ship via FedEx, DHL, UPS, EMS or other couriers with RT, or blue ice upon request. |
Description | (+/-)-Puerol B shows inhibitory activity on AGEs formation in vitro. |
In vitro | Phenolic compounds from Pueraria lobata protect PC12 cells against Aβ-induced toxicity.[Pubmed: 21052940 ]Arch Pharm Res. 2010 Oct;33(10):1651-4.
Constituents of the roots of Pueraria lobata inhibit formation of advanced glycation end products (AGEs).[Pubmed: 17121174 ]Arch Pharm Res. 2006 Oct;29(10):821-5.
|
Puerol B Dilution Calculator
Puerol B Molarity Calculator
1 mg | 5 mg | 10 mg | 20 mg | 25 mg | |
1 mM | 3.202 mL | 16.0102 mL | 32.0205 mL | 64.041 mL | 80.0512 mL |
5 mM | 0.6404 mL | 3.202 mL | 6.4041 mL | 12.8082 mL | 16.0102 mL |
10 mM | 0.3202 mL | 1.601 mL | 3.202 mL | 6.4041 mL | 8.0051 mL |
50 mM | 0.064 mL | 0.3202 mL | 0.6404 mL | 1.2808 mL | 1.601 mL |
100 mM | 0.032 mL | 0.1601 mL | 0.3202 mL | 0.6404 mL | 0.8005 mL |
* Note: If you are in the process of experiment, it's necessary to make the dilution ratios of the samples. The dilution data above is only for reference. Normally, it's can get a better solubility within lower of Concentrations. |
Calcutta University
University of Minnesota
University of Maryland School of Medicine
University of Illinois at Chicago
The Ohio State University
University of Zurich
Harvard University
Colorado State University
Auburn University
Yale University
Worcester Polytechnic Institute
Washington State University
Stanford University
University of Leipzig
Universidade da Beira Interior
The Institute of Cancer Research
Heidelberg University
University of Amsterdam
University of Auckland
TsingHua University
The University of Michigan
Miami University
DRURY University
Jilin University
Fudan University
Wuhan University
Sun Yat-sen University
Universite de Paris
Deemed University
Auckland University
The University of Tokyo
Korea University
- 1-Phenyl-2-propanol
Catalog No.:BCN8787
CAS No.:14898-87-4
- 5-Hydroxy-1-(4-hydroxyphenyl)-7-phenyl-3-heptanone (AO 2210)
Catalog No.:BCN8786
CAS No.:105955-04-2
- Lanceolarin
Catalog No.:BCN8785
CAS No.:15914-68-8
- Specioside B
Catalog No.:BCN8784
CAS No.:126589-95-5
- 7-(4-hydroxy-3-methoxyphenyl)-1-phenylhept-4-en-3-one (DPHB)
Catalog No.:BCN8782
CAS No.:79559-60-7
- Dehydrojuncusol
Catalog No.:BCN8780
CAS No.:117824-04-1
- Isonardosinone
Catalog No.:BCN8779
CAS No.:27062-01-7
- Maculosidin
Catalog No.:BCN8778
CAS No.:522-19-0
- Silychristin B
Catalog No.:BCN8777
CAS No.:879325-58-3
- Yuanhunine
Catalog No.:BCN8776
CAS No.:104387-15-7
- 3-O-[5'''-O-feruloyl-beta-D-apiofuranosyl(1'''->2'')-beta-D-glucopyranosyl] rhamnocitrin
Catalog No.:BCN8775
CAS No.:148210-00-8
- Licoricesaponin H2(18beta,20alpha-Glycyrrhizic acid)
Catalog No.:BCN8774
CAS No.:118441-85-3
- Gardenin D
Catalog No.:BCN8789
CAS No.:29202-00-4
- Emodin-8-O-beta-gentiobioside
Catalog No.:BCN8790
CAS No.:66466-22-6
- 5-Hydroxy-7-(4'-hydroxy-3'-methoxyphenyl)-1-phenyl-3-heptanone (DHPA)
Catalog No.:BCN8791
CAS No.:79559-61-8
- 4-Hydroxybenzoyl choline
Catalog No.:BCN8793
CAS No.:5094-31-5
- Patulitrin
Catalog No.:BCN8794
CAS No.:19833-25-1
- 7-(4-Hydroxyphenyl)-1-phenyl-4-hepten-3-one
Catalog No.:BCN8795
CAS No.:100667-52-5
- 3,7,25-Trihydroxycucurbita-5,23-dien-19-al
Catalog No.:BCN8799
CAS No.:85372-65-2
- Yuankanin
Catalog No.:BCN8755
CAS No.:77099-20-8
- New biochemical 1
Catalog No.:BCN8781
CAS No.:
- Complanatoside C
Catalog No.:BCN8783
CAS No.:
- New biochemical 2
Catalog No.:BCN8792
CAS No.:
- Polygalin J
Catalog No.:BCN8796
CAS No.:
Isolation and structure elucidation of bioactive compounds from the roots of the Tunisian Ononis angustissima L.[Pubmed:26248805]
Bioorg Med Chem Lett. 2015 Sep 15;25(18):3825-30.
A phytochemical investigation of the roots of Ononis angustissima L. (Fabaceae) offered to the bio-guided isolation of new isoflavone 3-(4-(glucopyranosyloxy)-5-hydroxy-2-methoxyphenyl)-7-hydroxy-4H-chromen-4-one 1, together with nine known compounds, ononin 2, formononetin 3, (+)-puerol A-2'-O-beta-D-glucose 4, (-)-Puerol B-2'-O-beta-D-glucopyranose ((-)-sophoraside A) 5, (+)-puerol A 6, (-)-trifolirhizin 7, (-)-trifolirhizin-6'-O-malonate 8, (-)-maackiain 9 and (-)-medicarpin 10. Compounds 2-10 were isolated and identified for the first time in Ononis angustissima. We investigated antioxidant capacities of isolated molecules and results showed that compound 6 exhibited the highest antioxidant activity with IC50 values of 19.53 mug/mL, 28.29 mug/mL and 38.53 mug/mL by DPPH radical, ABTS radical cation and reducing power assay, respectively, and an interesting IC50 (20.45 mug/mL) of 1 against DPPH. In addition, the neuroprotective activity of six isolated molecules (4-7, 9, 10) were evaluated. Following the exposure of PC12 cells to Abeta25-35, compounds 9 and 10 triggered a significant increase of cell viability and in a dose dependent manner.
[Studies on biotransformation of chemical constituents of tongmai formula by human intestinal flora].[Pubmed:24490564]
Zhongguo Zhong Yao Za Zhi. 2013 Oct;38(20):3510-9.
To study the chemical constituents in Tongmai formula (TMF) after biotransformation by human intestinal flora (HIF), water extract of TMF was anaerobically incubated with HIF at 37 degrees C. Column chromatographic methods over silica gel, Sephadex LH-20 and semi-preparative high-performance liquid chromatography as well as recrystallization were used to isolate and purify the chemical constituents in TMF after biotransformation by HIF. The chemical structures of isolated compounds were identified on the basis of MS and NMR data. Twenty-six compounds were obtained and identified as phenylpropionic acid (1), 6"-O-acetylpuerarin (2), formononetin(3), daidzein(4), p-hydroxyphenylpropionic acid (5), 3-indolepropionic acid (6), genistein (7), isoformononetin (8), isoononin (9), a mixture of (-)-Puerol B-2"-O-glucopyranoside (10a) and (+) -Puerol B-2"-O-glucopyranoside (10b), 8-hydroxydaidzein (11), puerol A (12), 3'-methoxy-6"-O-acetylpuerarin (13), 6"-O-acetyldaidzin (14), 3'-methoxydaidzin (15), Puerol B (16), 3-methyluracil (17), genistin (18), daidzin (19), 3'-methoxypuerarin (20), mirificin (21), swertiamarin (22) , daidzein-7, 4'-O-glucoside (23), adenine (24), 3'-hydroxypuerarin (25), and puerarin (26). After biotransformation by HIF, the glycosides in TMF were transformed into aglycone and/or less glycosyl compounds along with some hydroxylation and demethylation reactions. Therefore, the glycosides in the TMF are the pro-drug.
[Chemical constituents from roots of Pueraria lobata].[Pubmed:21355238]
Zhongguo Zhong Yao Za Zhi. 2010 Dec;35(23):3156-60.
OBJECTIVE: To study the chemical constituents in the roots of Pueraria lobata. METHOD: Various chromatographic methods were employed to separate of chemical constituents and the spectroscopic methods were used to elucidate the structure. RESULT: Twenty-two compounds were isolated and characterized as beta-sitosterol palmitate (1), beta-sitosterol (2), lupeol (3), lupeone (4) , puerarol (5), diisobutyl phthalate (6), bis(2-ethylhexyl) phthalate (7), sophoracoumestan A (8), coumestrol (9), allantion (10), dadzein (11), formononetin (12), 3'-methoxy daidzein (13), ononin (14), 3'-hydroxy dadzein (15), genistin (16), dadzin (17), 8-methoxy ononin (18), sissotorin (19), (-)-Puerol B 2-O-glucopyranoside (20), (6S,9R)-roseoside (21) and sucrose (22), respectively. CONCLUSION: Compounds 1, 5-8, 15, 18, 21 and 22 were isolated from P. lobata for the first time, and componds 1, 5-7, 15, 18, 21 and 22 were isolated from the genus Pueraria for the first time.
Phenolic compounds from Pueraria lobata protect PC12 cells against Abeta-induced toxicity.[Pubmed:21052940]
Arch Pharm Res. 2010 Oct;33(10):1651-4.
Bioassay-guided fractionation of the EtOAc-soluble extract of Pueraria lobata based on the inhibition of Abeta-induced toxicity in PC12 cells resulted in the isolation of four known active compounds, genistein (8), biochanin A (9), sissotrin (10), and Puerol B (11). Of these, genistein (8) and biochanin A (9) exhibited potent neuroprotective effects with ED(50) values of 33.7 and 27.8 muM, respectively. In addition, a new coumestan, 2-(alpha,alpha-dimethylallyl)coumestrol (1) was isolated and characterized, but proved to be inactive, as were additional seven known compounds. The structure of new compound 1 was determined using spectroscopic techniques.
Constituents of the roots of Pueraria lobata inhibit formation of advanced glycation end products (AGEs).[Pubmed:17121174]
Arch Pharm Res. 2006 Oct;29(10):821-5.
Two isoflavone C-glucosides, puerarin (1) and PG-3 (2), a but-2-enolide, (+/-)-Puerol B (3), two isoflavone O-glucosides, daidzin (4) and genistin (5), and three pterocarpans, (-)-medicarpin (6), (-)-glycinol (7) and (-)-tuberosin (8), were isolated from a MeOH extract of the roots of Pueraria lobata, using an in vitro bioassay based on the inhibition of the formation of advanced glycation end products (AGEs) to monitor chromatographic fractionation. The structures of 1-8 were determined by spectroscopic data interpretation, particularly by 1D- and 2D-NMR studies, and by comparison of these data with values in the literature. All of the isolates (1-8) were evaluated for their inhibitory activity on AGEs formation in vitro. Of these, puerarin (1), PG-3 (2), and (+/-)-Puerol B (3) exhibited more potent inhibitory activity than the positive control aminoguanidine.